Financial results - HELAPHARM WAREHOUSE DISTRIBUTION SRL

Financial Summary - Helapharm Warehouse Distribution Srl
Unique identification code: 29035252
Registration number: J2011001308291
Nace: 4781
Sales - Ron
1.176.749
Net Profit - Ron
142.018
Employees
3
Open Account
Company Helapharm Warehouse Distribution Srl with Fiscal Code 29035252 recorded a turnover of 2024 of 1.176.749, with a net profit of 142.018 and having an average number of employees of 3. The company operates in the field of CAEN Ver.3: Comerţ cu amănuntul al autovehiculelor; CAEN Ver.2: Comert cu amanuntul al produselor alimentare, bauturilor si produselor din tutun efectuat prin standuri, chioscuri si piete; having the NACE code 4781.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Helapharm Warehouse Distribution Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 3.177.400 943.582 17.205 748.304 720.297 361.993 696 2.959.537 2.438.649 1.176.749
Total Income - EUR 3.178.773 974.362 141.205 1.384.795 621.719 740.605 2.099.812 4.376.930 2.720.614 1.645.724
Total Expenses - EUR 3.091.090 1.027.011 209.773 702.283 241.679 787.850 1.804.977 4.247.505 2.342.535 1.468.124
Gross Profit/Loss - EUR 87.683 -52.649 -68.568 682.512 380.040 -47.245 294.835 129.425 378.080 177.600
Net Profit/Loss - EUR 73.432 -52.649 -77.512 673.102 370.541 -51.100 294.372 115.534 342.096 142.018
Employees 3 4 2 2 1 4 3 3 2 3
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales decreased by -51.5%, from 2.438.649 euro in the year 2023, to 1.176.749 euro in 2024. The Net Profit decreased by -198.166 euro, from 342.096 euro in 2023, to 142.018 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Helapharm Warehouse Distribution Srl

Rating financiar

Financial Rating -
HELAPHARM WAREHOUSE DISTRIBUTION...

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Helapharm Warehouse Distribution...

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Helapharm Warehouse Distribution...

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Helapharm Warehouse Distribution...

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Helapharm Warehouse Distribution Srl - CUI 29035252

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 281.140 652.170 763.234 1.082.754 1.196.172 1.242.552 782.803 639.489 632.816 560.150
Current Assets 536.361 555.379 309.903 1.067.526 417.313 213.385 2.495.604 3.724.027 3.873.753 4.506.734
Inventories 95.423 7 18 396.758 909 891 2.361.330 3.507.724 3.198.684 4.133.099
Receivables 223.969 472.886 37.752 590.072 160.239 102.003 91.415 102.989 456.652 212.446
Cash 216.969 82.486 272.133 80.696 256.698 28.333 42.859 113.314 218.417 161.189
Shareholders Funds 653.148 593.839 506.278 1.170.088 1.517.283 1.437.418 1.672.388 1.793.536 2.042.731 2.229.490
Social Capital 45 45 44 43 42 41 40 41 40 40
Debts 164.352 613.710 566.859 1.017.246 119.804 93.951 831.845 2.124.715 2.685.533 2.760.984
Income in Advance 0 0 0 31.020 44.396 78.201 991.538 568.214 29.082 275.071
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4781 - 4781"
CAEN Financial Year 4120
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 4.506.734 euro in 2024 which includes Inventories of 4.133.099 euro, Receivables of 212.446 euro and cash availability of 161.189 euro.
The company's Equity was valued at 2.229.490 euro, while total Liabilities amounted to 2.760.984 euro. Equity increased by 198.175 euro, from 2.042.731 euro in 2023, to 2.229.490 in 2024. The Debt Ratio was 52.4% in the year 2024.

Risk Reports Prices

Reviews - Helapharm Warehouse Distribution Srl

Comments - Helapharm Warehouse Distribution Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.